Literature DB >> 29698387

Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Zhuo-Ming Li1, Suo-Wen Xu2, Pei-Qing Liu1.   

Abstract

Salvia miltiorrhiza Burge (Danshen) is an eminent medicinal herb that possesses broad cardiovascular and cerebrovascular protective actions and has been used in Asian countries for many centuries. Accumulating evidence suggests that Danshen and its components prevent vascular diseases, in particular, atherosclerosis and cardiac diseases, including myocardial infarction, myocardial ischemia/reperfusion injury, arrhythmia, cardiac hypertrophy and cardiac fibrosis. The published literature indicates that lipophilic constituents (tanshinone I, tanshinone IIa, tanshinone IIb, cryptotanshinone, dihydrotanshinone, etc) as well as hydrophilic constituents (danshensu, salvianolic acid A and B, protocatechuic aldehyde, etc) contribute to the cardiovascular protective actions of Danshen, suggesting a potential synergism among these constituents. Herein, we provide a systematic up-to-date review on the cardiovascular actions and therapeutic potential of major pharmacologically active constituents of Danshen. These bioactive compounds will serve as excellent drug candidates in small-molecule cardiovascular drug discovery. This article also provides a scientific rationale for understanding the traditional use of Danshen in cardiovascular therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29698387      PMCID: PMC5943903          DOI: 10.1038/aps.2017.193

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  360 in total

1.  Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor.

Authors:  Chun-Hsu Pan; Ching-Wen Chen; Ming-Jyh Sheu; Chieh-Hsi Wu
Journal:  Vascul Pharmacol       Date:  2011-12-04       Impact factor: 5.773

2.  [Protection of vascular endothelial cells from ox-LDL induced injury by protocatechualdehyde].

Authors:  Chun-jie Han; Rong Lin; Jun-tian Liu; Yu Liu; Hui Zhang
Journal:  Zhong Yao Cai       Date:  2007-12

3.  Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats.

Authors:  Y Zhang; L Wei; D Sun; F Cao; H Gao; L Zhao; J Du; Y Li; H Wang
Journal:  Diabetes Obes Metab       Date:  2010-04       Impact factor: 6.577

Review 4.  New developments in the chemistry and biology of the bioactive constituents of Tanshen.

Authors:  Xihong Wang; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2007-01       Impact factor: 12.944

5.  Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction.

Authors:  K Chan; S H Chui; D Y L Wong; W Y Ha; C L Chan; R N S Wong
Journal:  Life Sci       Date:  2004-11-12       Impact factor: 5.037

6.  Protective roles of puerarin and Danshensu on acute ischemic myocardial injury in rats.

Authors:  L Wu; H Qiao; Y Li; L Li
Journal:  Phytomedicine       Date:  2007-09-17       Impact factor: 5.340

7.  Tanshinone IIA selectively enhances hyperpolarization-activated cyclic nucleotide-modulated (HCN) channel instantaneous current.

Authors:  Qiansheng Liang; Le Yang; Zhaohua Wang; Sufang Huang; Shusheng Li; Guangtian Yang
Journal:  J Pharmacol Sci       Date:  2009-07       Impact factor: 3.337

8.  Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation.

Authors:  Ruifang Yang; Aijun Liu; Xiujuan Ma; Lin Li; Dingfeng Su; Jianguo Liu
Journal:  J Cardiovasc Pharmacol       Date:  2008-04       Impact factor: 3.105

Review 9.  Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy.

Authors:  Shrey Kohli; Suchit Ahuja; Vibha Rani
Journal:  Curr Cardiol Rev       Date:  2011-11

10.  Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene.

Authors:  Tiechan Zhao; Lianying Chang; Boyong Zhang; Ming Lu; Xiaoyi Wang; John O Orgah; Yuefei Wang; Xiaoxuan Tian; Jing Yang; Guanwei Fan; Boli Zhang; Yan Zhu
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

View more
  78 in total

1.  Culture Separation, Identification and Unique Anti-pathogenic Fungi Capacity of Endophytic Fungi from Gucheng Salvia Miltiorrhiza.

Authors:  DA-Tian Bau; Wen-Shin Chang; Guo-Kai Wang; Jai-Sing Yang; Yu-Fei Huang; Jin-Song Liu; Chia-Wen Tsai
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  A new platform for international collaboration on pharmacology and drug development: 2017 China-Canada-USA Pharmacology/Physiology Conference.

Authors:  Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-05       Impact factor: 6.150

3.  Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.

Authors:  Peipei Luo; Yanqiang Huang; Xudong Hang; Qian Tong; Liping Zeng; Jia Jia; Guoxin Zhang; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  Danshensu Ameliorates Cardiac Ischaemia Reperfusion Injury through Activating Sirt1/FoxO1/Rab7 Signal Pathway.

Authors:  Da-Wei Sun; Qing Gao; Xin Qi
Journal:  Chin J Integr Med       Date:  2019-06-28       Impact factor: 1.978

Review 5.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

6.  Danlou Tablet Improves Chronic Intermittent Hypoxia-Induced Dyslipidemia and Arteriosclerosis by HIF-1α-Angptl4 mRNA Signaling Pathway.

Authors:  Jing-Jing Tang; Guang-Xi Li; Zhi-Guo Liu; Rong Yi; Dong Yu; Yue-Bo Zhang; Shuang-Qiao Zhao; Shi-Han Wang
Journal:  Chin J Integr Med       Date:  2020-07-04       Impact factor: 1.978

Review 7.  The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.

Authors:  Yuehui Zhang; Xiaozhu Guo; Shuting Ma; Haoyue Ma; Hang Li; Yi Wang; Zhen Qin; Xiaoke Wu; Yaguang Han; Yanhua Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.629

Review 8.  Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis.

Authors:  Luxia Song; Jie Zhang; Runmin Lai; Qiuyi Li; Jianqing Ju; Hao Xu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

9.  ITRAQ-based proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells of adenomyosis.

Authors:  Yong Luo; Zeng-Ming Li; Li-Ping Li; Yang Zou; Xiao-Yun Xu; Zi-Yu Zhang; Fa-Ying Liu; Yan Xiong; Lei Wan
Journal:  Arch Gynecol Obstet       Date:  2021-01-20       Impact factor: 2.344

10.  RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization.

Authors:  Junxiu Zhang; Jingyi Zhu; Lingzhou Zhao; Ke Mao; Qing Gu; Dongli Li; Jinhua Zhao; Xingwei Wu
Journal:  J Nanobiotechnology       Date:  2021-07-02       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.